


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.18%
+3.61%
+16.15%
-3.87%
TVTX
Travere Therapeutics
$28.47
Strengths

Earnings are forecast to grow

Trading below its fair value
TVTX Price Performance
$30.22 (-5.79%)
$34.83 (-18.26%)
$26.85 (+6.03%)
$20.79 (+36.94%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TVTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TVTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TVTX has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 18, 2026
Price Target Raised
Buy
Piper Sandler
Nov 28, 2025
Reiterate
Buy
HC Wainwright & Co.
Oct 15, 2025
Upgrade
Buy
Zacks
What is TVTX current stock price?
What are TVTX stock strengths?
What is TVTX Risk Level?
What is TVTX market cap and volume?
What is TVTX current Stock IQ?
Should I buy TVTX stock right now?
Is TVTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for TVTX?
What does a 'Strong Sell' rating mean for TVTX?
What factors influence TVTX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
TVTX
Travere Therapeutics
Current Price
$28.47

TVTX Price Performance
$30.22 (-5.79%)
$34.83 (-18.26%)
$26.85 (+6.03%)
$20.79 (+36.94%)
TVTX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TVTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TVTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TVTX has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
TVTX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value
TVTX Latest Analysis
LGND: 2025 Results & Focus on Qtorin. By John Vandermosten CFANASDAQ:LGNDREAD THE FULL LGND RESEARCH REPORTLigand Pharmaceuticals Inc. (NASDAQ:LGND) reported 2025 results with revenues of $268 million and adjusted core earnings per share (EPS) of $8.13. Both numbers were substantially better than initial and revised 2025 guidance. Isolating the fourth quarter results revenues from royalties were markedly better than our estimates while Captisol revenue was slightly below and the highly volatile
Mon Mar 2, 2026
Travere Therapeutics Non-GAAP EPS of $0.37 in-line revenue of $129.69M misses by $17.99M.
Thu Feb 19, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TVTX Stock trends
TVTX Stock performance
TVTX Stock analysis
TVTX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.